High risk of failing eradication of Helicobacter pylori in patients with diabetes: A meta-analysis
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. Practice Parameters Committee of the American College of Gastroenterology American College of Gastroenterology guideline on the management of Helicobacter pylori infection;Chey;Am J Gastroenterol,2007
2. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?;Fuccio;Ann Intern Med,2009
3. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis;Ford;Am J Gastroenterol,2004
4. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies;Zhou;Diabetes Res Clin Pract,2013
5. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis;Fine;J Am Med Assoc,1996
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The significance of chronic hyperglycemia for the reduced efficacy of eradication therapy in patients with type 2 diabetes mellitus and for Helicobacter pylori survival;Exploration of Digestive Diseases;2023-12-27
2. Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study;Journal of Gastroenterology;2023-10-01
3. Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?;Gut and Liver;2023-09-15
4. Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study;Gut and Liver;2022-12-13
5. Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?;Gut Pathogens;2022-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3